Researchers at the University of Iowa found that adding high-dose IV vitamin C to chemotherapy helped increase survival in ...

Many individual factors play a role in survival rates. Newer treatments are helping extend lives and improve the quality of life for people with metastatic breast cancer. Metastatic breast cancer ...

Whereas metastatic castrate-resistant prostate cancer used to have a poor prognosis, new agents are available and continuing to emerge with the potential to extend survival, but there is no ...

In the last few years, large Phase III trials showed improvements in survival and outcomes ... Intravenous; mCRPC: Metastatic castration-resistant prostate cancer; P: Placebo; PSA: Prostate ...

A high dose of one vitamin was found to double survival rates of late stage pancreatic cancer, according to a new study ...

A study from researchers at the University of Michigan and the University of California San Diego has shed light on a previously poorly understood aspect of breast cancer recurrence: how cancer cells ...

In fact, Tavazoie and colleagues had previously demonstrated that various germline alleles of APOE can enhance or suppress melanoma metastasis. To find out whether breast cancer metastasis operates in ...

Radium-223, enzalutamide, and a bone-protecting agent may be a new treatment option for mCRPC patients with bone metastases, according to Silke Gillessen, MD.

The company's ‘Zeta” platform encompasses the following oncological drug candidates ZetaMet™ (Zeta-BC-003), ZetaMet-P™ (Zeta-PC-004) and ZetaMAST™ (Zeta-MBC-005). To learn more, visit www.zetagen.com ...

Truqap combination showed a statistically and clinically meaningful improvement in radiographic progression-free survival for ...

Elacestrant, a selective estrogen receptor degrader, demonstrated significant improvements in progression-free survival (PFS) ...